Interferon-complement loop in transplant-associated thrombotic microangiopathy

Transplant-associated thrombotic microangiopathy (TA-TMA) is an important cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). The complement inhibitor eculizumab improves TA-TMA, but not all patients respond to therapy, prompting a search for additional targetable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Jodele, Sonata, Medvedovic, Mario, Luebbering, Nathan, Chen, Jenny, Dandoy, Christopher E., Laskin, Benjamin L., Davies, Stella M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7094010/
https://ncbi.nlm.nih.gov/pubmed/32208488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados